0001558370-20-004920.txt : 20200604 0001558370-20-004920.hdr.sgml : 20200604 20200501162001 ACCESSION NUMBER: 0001558370-20-004920 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20200501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ampio Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411906 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260179592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 200 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 720-437-6500 MAIL ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 200 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: Chay Enterprises, Inc. DATE OF NAME CHANGE: 20070910 CORRESP 1 filename1.htm ampe_Current_Folio_Corresp

Picture 1

 

May 1, 2020

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Ampio Pharmaceuticals, Inc.

Acceleration Request for Registration Statement on Form S-3

File No. 333-237723

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Ampio Pharmaceuticals, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to May 4, 2020, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Squire Patton Boggs (US) LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

 

If you have any questions regarding this request, please contact Leah Brownlee of Squire Patton Boggs (US) LLP at (216) 479-8549.

 

 

 

 

 

 

Sincerely,

 

 

 

 

AMPIO PHARMACEUTICALS, INC.

 

 

 

/s/ Daniel Stokely

 

Name:

Daniel Stokely

 

Title:

Chief Financial Officer

 

 

 

 

 

cc:

Leah Brownlee, Squire Patton Boggs (US) LLP

 

373 Inverness Parkway

Suite 200

Englewood, CO 80112 USA

 

www.ampiopharma.com

 

GRAPHIC 2 tmb-20200501xcorrespg001.jpg GRAPHIC begin 644 tmb-20200501xcorrespg001.jpg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end